Michael Makris on Non-Malignant Haematology
Michael Makris, Emeritus Professor of Haemostasis and Thrombosis at the University of Sheffield, shared on LinkedIn:
”What do you call the specialty of “non-malignant haematology”?
Everybody agrees that non-malignant haematology is not a good term.
Our US colleagues, backed by ASH, have chosen to go with “Classical Hematology”.
I have discussed this with colleagues in the UK and Europe, and have not met a single haematologist who likes the term Classical Haematology.
We now have a new name proposed: Medical Haematology.
A paper in the British Journal of Haematology discusses this in detail, including why this term is preferred to Classical Haematology, and also how this is integrated with hospital medicine and the future of the specialty.
My personal view is that our specialty should be called Medical not Classical Haematology.”
Read the full article here.
Article: Medical haematology: Repositioning haematology at the centre of medicine
Authors: Cheng Hock Toh, Imelda Bates, Sue Pavord

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 16:21Alessandra Bosch: Women and Girls With Bleeding Disorders and the DACH Registries at HHS 2026
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events
-
Nov 8, 2026, 14:05Kausik Ray: Plaque-Guided Care for Better Coronary Outcomes
-
Nov 8, 2026, 14:05Athira Elssa Johnson: Understanding Coronary Thrombosis and Its Risks
-
Nov 8, 2026, 14:04Sanjiv Beri: Blood Type Compatibility and the Balance of Giving and Receiving
-
Nov 8, 2026, 14:02Gabriela Hobbs: Recognizing Outstanding Abstract Achievements-ASH 2026
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition